Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 364

1.

Model-Based Deep Brain Stimulation Programming for Parkinson's Disease: The GUIDE Pilot Study.

Pourfar MH, Mogilner AY, Farris S, Giroux M, Gillego M, Zhao Y, Blum D, Bokil H, Pierre MC.

Stereotact Funct Neurosurg. 2015 May 14;93(4):231-239. [Epub ahead of print]

PMID:
25998447
2.

Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms.

Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez FJ, Laurent C, Demeyer D, Carrier S, Buée-Scherrer V, Blum D, Vinh J, Sergeant N, Verdier Y, Buée L, Hamdane M.

Sci Rep. 2015 May 14;5:9659. doi: 10.1038/srep09659.

3.

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.

Jacobson MP, Pazdera L, Bhatia P, Grinnell T, Cheng H, Blum D; study 046 team.

BMC Neurol. 2015 Mar 28;15:46. doi: 10.1186/s12883-015-0305-5.

4.

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: A randomized historical-control phase III study based in North America.

Sperling MR, Harvey J, Grinnell T, Cheng H, Blum D; 045 Study Team.

Epilepsia. 2015 Apr;56(4):546-55. doi: 10.1111/epi.12934. Epub 2015 Feb 16.

PMID:
25689448
5.

Registered report: transcriptional amplification in tumor cells with elevated c-Myc.

Blum D, Hao H, McCarthy M; Reproducibility Project: Cancer Biology.

Elife. 2015 Jan 26;4. doi: 10.7554/eLife.04024.

6.

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.

Sperling MR, Abou-Khalil B, Harvey J, Rogin JB, Biraben A, Galimberti CA, Kowacs PA, Hong SB, Cheng H, Blum D, Nunes T, Soares-da-Silva P; 304 Study Team.

Epilepsia. 2015 Feb;56(2):244-53. doi: 10.1111/epi.12894. Epub 2014 Dec 22.

7.

Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.

Blum D, LaBarge S; Reproducibility Project: Cancer Biology.

Elife. 2014 Dec 10;3. doi: 10.7554/eLife.04034.

8.

A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, Hamdane M, Humez S, Müller CE, Lopes LV, Buée L, Blum D.

Mol Psychiatry. 2014 Dec 2. doi: 10.1038/mp.2014.151. [Epub ahead of print]

PMID:
25450226
9.

Rescue of impaired late-phase long-term depression in a tau transgenic mouse model.

Ahmed T, Blum D, Burnouf S, Demeyer D, Buée-Scherrer V, D'Hooge R, Buée L, Balschun D.

Neurobiol Aging. 2015 Feb;36(2):730-9. doi: 10.1016/j.neurobiolaging.2014.09.015. Epub 2014 Sep 28.

PMID:
25443285
10.

Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice.

Martel G, Simon A, Nocera S, Kalainathan S, Pidoux L, Blum D, Leclère-Turbant S, Diaz J, Geny D, Moyse E, Videau C, Buée L, Epelbaum J, Viollet C.

Neurobiol Aging. 2015 Feb;36(2):1013-28. doi: 10.1016/j.neurobiolaging.2014.10.033. Epub 2014 Oct 31.

PMID:
25433460
11.

Computer-Based Clinical Decision Support Systems and Patient-Reported Outcomes: A Systematic Review.

Blum D, Raj SX, Oberholzer R, Riphagen II, Strasser F, Kaasa S; EURO IMPACT, European Intersectorial Multidisciplinary Palliative Care Research Training.

Patient. 2014 Nov 29. [Epub ahead of print]

PMID:
25432150
12.

Nursing Activities Score and workload in the intensive care unit of a university hospital.

Altafin JA, Grion CM, Tanita MT, Festti J, Cardoso LT, Veiga CF, Kamiji D, Barbosa ÁR, Matsubara CC, Lara AB, Lopes CC, Blum D, Matsuo T.

Rev Bras Ter Intensiva. 2014 Jul-Sep;26(3):292-8. English, Portuguese.

13.

Mutant huntingtin alters Tau phosphorylation and subcellular distribution.

Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E, Buée L, Outeiro TF.

Hum Mol Genet. 2015 Jan 1;24(1):76-85. doi: 10.1093/hmg/ddu421. Epub 2014 Aug 20.

PMID:
25143394
14.

Self-report measurement of pain & symptoms in palliative care patients: a comparison of verbal, visual and hand scoring methods in Sub-Saharan Africa.

Blum D, Selman LE, Agupio G, Mashao T, Mmoledi K, Moll T, Dinat N, Gwyther L, Sebuyira LM, Ikin B, Downing J, Kaasa S, Higginson IJ, Harding R.

Health Qual Life Outcomes. 2014 Aug 2;12:118. doi: 10.1186/s12955-014-0118-z.

15.

PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments.

Chaalal A, Poirier R, Blum D, Gillet B, Le Blanc P, Basquin M, Buée L, Laroche S, Enderlin V.

Hippocampus. 2014 Nov;24(11):1381-93. doi: 10.1002/hipo.22319. Epub 2014 Jul 22.

PMID:
24978200
16.

Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion.

Ahmed T, Van der Jeugd A, Blum D, Galas MC, D'Hooge R, Buee L, Balschun D.

Neurobiol Aging. 2014 Nov;35(11):2474-8. doi: 10.1016/j.neurobiolaging.2014.05.005. Epub 2014 May 10.

PMID:
24913895
17.

No evidence of neuroprotection? Perhaps not...perhaps so.

Lewin MR, Blum DP.

Parkinsonism Relat Disord. 2014 Sep;20(9):1037. doi: 10.1016/j.parkreldis.2014.05.002. Epub 2014 May 14. No abstract available.

PMID:
24880962
18.

Development and validation of a medical chart review checklist for symptom management performance of oncologists in the routine care of patients with advanced cancer.

Blum D, Rosa D, deWolf-Linder S, Hayoz S, Ribi K, Koeberle D, Strasser F.

J Pain Symptom Manage. 2014 Dec;48(6):1160-7. doi: 10.1016/j.jpainsymman.2014.04.009. Epub 2014 May 23.

PMID:
24863153
19.

Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain.

Jerónimo-Santos A, Vaz SH, Parreira S, Rapaz-Lérias S, Caetano AP, Buée-Scherrer V, Castrén E, Valente CA, Blum D, Sebastião AM, Diógenes MJ.

Cereb Cortex. 2014 May 23. pii: bhu105. [Epub ahead of print]

PMID:
24860020
20.

Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.

Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, Schneider M, Hamdane M, Müller CE, Buée L, Blum D.

Neurobiol Aging. 2014 Sep;35(9):2079-90. doi: 10.1016/j.neurobiolaging.2014.03.027. Epub 2014 Mar 29.

PMID:
24780254
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk